FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and discloses the use of the peptide Met-Glu-His-Phe-Pro-Gly-Pro (semax) in dose of 450 mcg/kg to achieve an adaptogenic effect with short-term physical activity.
EFFECT: achieving adaptogenic effect with short-term physical activity.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PEPTIDE MET-GLU-HIS-PHE-PRO-GLY-PRO (SEMAX) FOR MAINTAINING VEGETATIVE BALANCE DURING PHYSICAL ACTIVITY | 2023 |
|
RU2813468C1 |
| USE OF PEPTIDE Met-Glu-His-Phe-Pro-Gly-Pro (Semax) FOR DYSBIOSIS CORRECTION IN CHRONIC IMMOBILIZATION STRESS | 2019 |
|
RU2709527C1 |
| MEDICINAL PRODUCT AND METHOD OF TREATING VERTIGO | 2013 |
|
RU2577136C2 |
| USE OF PEPTIDE OF FORMULA MET-GLU-HIS-PHE-PRO-GLY-PRO FOR TREATING ANOSMIA IN COVID-19 | 2023 |
|
RU2816583C1 |
| METHOD OF TREATING VEGETATIVE-VASCULAR DYSTONIA AND MEDICINAL PRODUCT | 2013 |
|
RU2577130C2 |
| ANTI-THROMBOSIS, ANTICOAGULANT, FIBRIN DEPOLYMERIZING, FIBRINOLYTIC AGENT FOR INTRAVENOUS ADMINISTRATION | 2005 |
|
RU2286168C1 |
| NOOTROPIC DRUG AND PHARMACEUTICAL NOOTROPIC COMPOSITION | 1994 |
|
RU2045958C1 |
| ANTI-THROMBOSIS, ANTI-COAGULANT, FIBRIN-DEPOLYMERIZATION, FIBRINOLYTIC AGENT FOR INTRAMUSCULAR ADMINISTRATION | 2005 |
|
RU2288737C1 |
| ANTI-THROMBOSIS, ANTI-COAGULATING, FIBRIN-DEPOLYMERIZING AND FIBRINOLYTIC AGENT | 2005 |
|
RU2290194C1 |
| INJECTION DOSAGE FORM FOR TREATING ACUTE ISCHEMIC STROKE AND CRANIOCEREBERAL INJURY, METHOD FOR PREPARING AND USING | 2009 |
|
RU2431496C2 |
